News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) Escapes $482 Million Verdict As Court Rejects Patent Appeal


1/27/2014 9:01:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Supreme Court on Monday declined to hear an appeal from a radiologist seeking to reinstate a $482 million patent infringement award he had won against Cordis Corp. The decision leaves intact an appeals court ruling throwing out the 2011 jury award. In the April 2013 ruling, the U.S. Court of Appeals for the Federal Circuit said Cordis, a Johnson and Johnson subsidiary, did not infringe on a patent owned by the radiologist, Bruce Saffran, in making its Cypher stent.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at North Jersey


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES